Author

Sean W. Boland

Colorado State University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Anushree ChatterjeeiD· 2 shared Julie A. MorenoiD· 2 shared Prashant NagpaliD· 2 shared Sadhana SharmaiD· 2 shared Sydney J. RiseniD· 2 shared Vincenzo S. Gilberto· 2 shared Amanda S. LathamiD· 1 shared Amelia D. Hines· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Anushree ChatterjeeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model

Sadhana Sharma, Sydney J. Risen, Vincenzo S. Gilberto, Sean W. Boland, Anushree Chatterjee, Julie A. Moreno, Prashant Nagpal

This paper demonstrates that inflammasome-inhibiting Nanoligomers reduce neuroinflammation and improve outcomes in an EAE mouse model of MS.

ACS Chemical Neuroscience · Mar 25, 2024Peer-reviewedNeuroscience

Targeting neuroinflammation by pharmacologic down-regulation of inflammatory pathways is neuroprotective in protein misfolding disorders.

Sydney J. Risen, Sean W. Boland, Sadhana Sharma, Grace M. Weisman, Payton M. Shirley, Amanda S. Latham, Arielle J. D. Hay, Vincenzo S. Gilberto, Amelia D. Hines, Stephen M. Brindley, Jared M. Brown, Stephanie McGrath, Anushree Chatterjee, Prashant Nagpal, Julie A. Moreno

This paper shows that targeting neuroinflammation by down-regulating NF-κB and NLRP3 with SB_NI_112 protects against neurodegeneration in prion disease models.

ACS Chemical Neuroscience · Mar 20, 2024Peer-reviewedNeuroscience